Brief: Theravance Biopharma Announces Tender Offer For Outstanding 3.25% Convertible Senior Notes Due 2023
26/07/2022 13:59
July 26 (Reuters) - Theravance Biopharma Inc TBPH.O :
* THERAVANCE BIOPHARMA ANNOUNCES TENDER OFFER FOR
OUTSTANDING
3.25% CONVERTIBLE SENIOR NOTES DUE 2023
Source text for Eikon: ID:nPn8VQfRca
Further company coverage: TBPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions